Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Autonomix Medical Inc (AMIX)

Autonomix Medical Inc (AMIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company’s Proprietary Catheter-Based Technology

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Appoints Julie Manchester as VP of Regulatory Affairs to Advance FDA Approval Process for Innovative Sensing Technology

Autonomix Medical appoints Julie Manchester as VP of Regulatory Affairs, advancing towards FDA approval for its catheter-based technology.Quiver AI SummaryAutonomix Medical, Inc. has appointed Julie Manchester...

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality

AMIX : 3.43 (-8.78%)
Autonomix Medical Achieves Design Lock for First-in-Class RF Ablation Catheter Targeting Chronic Pain Relief, Plans IDE Submission and Pivotal Trial

Autonomix Medical announces design lock for its RF ablation catheter targeting pancreatic cancer pain, plans pivotal trial for FDA approval.Quiver AI SummaryAutonomix Medical, Inc. announced a significant...

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Public Offering of Common Stock Units and Pre-Funded Warrant Units

Autonomix Medical announces $9 million stock offering to fund clinical trials and research for innovative nerve-targeted treatments.Quiver AI SummaryAutonomix Medical, Inc. has announced a public offering...

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

AMIX : 3.43 (-8.78%)
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

AMIX : 3.43 (-8.78%)

Barchart Exclusives

Elon Musk Weighs In on Weight-Loss Drug Stocks. Is LLY or NVO a Better Buy?
Elon Musk’s preference for Eli Lilly’s Mounjaro over Novo Nordisk’s Ozempic has sparked increased interest in weight-loss drug stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar